PEPGEN INC (PEPG) Stock Price, Quote, News and Overview
NASDAQ:PEPG - Nasdaq - US7133171055 - Common Stock - Currency: USD
PEPG Quote, Performance and Key Statistics
2.29
+0.92 (+67.15%)
The current stock price of PEPG is 2.29 USD. In the past month the price increased by 18.04%. In the past year, price decreased by -86.22%.
PEPG Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.17 | 360.64B | ||
| AMGN | AMGEN INC | 15.63 | 166.32B | ||
| GILD | GILEAD SCIENCES INC | 24.08 | 138.34B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1660.86 | 123.74B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.63 | 77.97B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.04B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.11B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.04B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.58B | ||
| NTRA | NATERA INC | N/A | 20.91B | ||
| BIIB | BIOGEN INC | 8.58 | 20.59B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.73 | 15.99B |
Related stock screener links
About PEPG
Company Profile
PepGen Inc. develops oligonucleotide therapies. The company is headquartered in Cambridge, Massachusetts and currently employs 64 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. Its proprietary enhanced delivery oligonucleotide (EDO), platform leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake and nuclear delivery. Using these EDO peptides, the Company is generating a pipeline of oligonucleotide therapeutic candidates that are designed to target the root cause of serious diseases. The Company’s pipeline consists of two clinical stage programs: PGN-EDO51 for duchenne muscular dystrophy (DMD) patients who are amenable to exon 51-skipping and PGN-EDODM1 for myotonic dystrophy type 1 (DM1) patients. The company also has three additional preclinical stage programs: PGN-EDO53, PGN-EDO45 and PGN-EDO44.
Company Info
PEPGEN INC
245 Main St, 2nd Floor
Cambridge MASSACHUSETTS US
Employees: 72
Company Website: https://pepgen.com
Investor Relations: https://investors.pepgen.com/
Phone: 17034568000
PEPGEN INC / PEPG FAQ
What is the stock price of PEPGEN INC today?
The current stock price of PEPG is 2.29 USD. The price increased by 67.15% in the last trading session.
What is the ticker symbol for PEPGEN INC stock?
The exchange symbol of PEPGEN INC is PEPG and it is listed on the Nasdaq exchange.
On which exchange is PEPG stock listed?
PEPG stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for PEPGEN INC stock?
11 analysts have analysed PEPG and the average price target is 13.06 USD. This implies a price increase of 470.13% is expected in the next year compared to the current price of 2.29. Check the PEPGEN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PEPGEN INC worth?
PEPGEN INC (PEPG) has a market capitalization of 74.65M USD. This makes PEPG a Micro Cap stock.
How many employees does PEPGEN INC have?
PEPGEN INC (PEPG) currently has 72 employees.
Should I buy PEPGEN INC (PEPG) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PEPG, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PEPG, evaluating the profitability, health, valuation and growth aspects
- PEPGEN INC (PEPG) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PEPGEN INC (PEPG) Sales and EPS estimates to see what analysts future expectations are.
- PEPGEN INC (PEPG) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PEPGEN INC (PEPG) Insider and Institutional Ownership to learn about the owners and their transactions.
- PEPGEN INC (PEPG) Stock Chart to make your own analysis
- PEPGEN INC (PEPG) Latest news and press-releases to stay up to date.
Does PEPGEN INC (PEPG) stock pay dividends?
PEPG does not pay a dividend.
When does PEPGEN INC (PEPG) report earnings?
PEPGEN INC (PEPG) will report earnings on 2025-03-20, after the market close.
What is the Price/Earnings (PE) ratio of PEPGEN INC (PEPG)?
PEPGEN INC (PEPG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.97).
What is the Short Interest ratio of PEPGEN INC (PEPG) stock?
The outstanding short interest for PEPGEN INC (PEPG) is 2.28% of its float. Check the ownership tab for more information on the PEPG short interest.
PEPG Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to PEPG. When comparing the yearly performance of all stocks, PEPG is a bad performer in the overall market: 98.59% of all stocks are doing better.
PEPG Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PEPG. While PEPG has a great health rating, there are worries on its profitability.
PEPG Financial Highlights
Over the last trailing twelve months PEPG reported a non-GAAP Earnings per Share(EPS) of -2.97. The EPS decreased by -8.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -51.24% | ||
| ROE | -63.46% | ||
| Debt/Equity | 0 |
PEPG Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to PEPG. The Buy consensus is the average rating of analysts ratings from 11 analysts.